intellectual property


ISPs targeted in Pacific trade agreement
Representatives from Australia's internet industry have called for full disclosure of a proposed free trade agreement between the United States and its allies in the Pacific, concerned that the deal asks ISPs to shoulder onerous burdens around copyright infringement.
Price of medicines may sky-rocket with FTA
The price of medicine might be out of reach for most people if Malaysia inks an understanding with the European Union on the Free Trade Agreement.
India, Mercosur "must withstand EU pharma demands"
Nations currently negotiating trade deals with the European Union (EU) have been warned that they must resist European demands which could threaten access to medicines in emerging and developing countries.
No compromise in our stance on IPR, says India
India will not compromise its stand or take a position on intellectual property rights (IPR), especially on pharmaceuticals, beyond its domestic law and agreements as mandated under the aegis of the global trade body—World Trade Organization (WTO).
Europe opens new front against affordable medicines in trade deal with India
As free trade agreement talks between Europe and India resume in Brussels today, the international medical humanitarian organisation Médecins Sans Frontières (MSF) is deeply concerned about new measures Europe is pushing to restrict the production of affordable generic medicines that MSF and others rely on to treat patients across the developing world.
US trade demands a real sore point
What the United States is seeking on intellectual property in the transpacific trade talks has been leaked. Some of it looks downright sinister.
India will not provide data exclusivity: Anand Sharma
The government on Tuesday took a firm stand on protection of intellectual property rights and the aspect of data exclusivity for drug manufacturers saying that the country would not extend data exclusivity that would hamper the domestic pharma industry.
No data sharing on drugs of pharma cos in FTAs: Sharma
India today ruled out sharing test data of drugs, or data exclusivity, of Indian pharma firms with developed countries and multi-national companies, and stressed that the provision will not form part of any free trade agreements pursued by the country.
UN Special Raporteur on right to health asked to intervene in TPP Trade negotiation
Eleven public interest advocacy groups and three law professors have submitted a petition to Anand Grover, the Special Rapporteur for the United Nations on the right to health, to intervene in a new regional trade agreement that will shrink the market for legal generic medecines.
US IP enforcement ambitions in Trans-Pacific trade agreement stir reactions
An alleged official document leaked last week showed that the United States is taking the lead in escalating intellectual property rights enforcement in negotiations for a regional trade agreement among countries bordering the Pacific Ocean.